A man preparing to spray disinfectant around Klong Toey fresh market, after it was temporarily shut down due to several vendors testing positive for Covid-19, in Bangkok on Jan 14, 2021.- AFP
BANGKOK (The Straits Times/ANN): Thailand looked like it was ahead in the regional scramble for a coronavirus vaccine in October when it announced a local firm would manufacture the Oxford-AstraZeneca vaccine for domestic use and distribution to nearby countries.
But with a locally produced vaccine months away while local transmissions grew over the new year, Thailand sought to boost its initial reservation of 26 million doses.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
